RWD149 Reduction in Ischemic Stroke Rates in Patients With Non-Valvular Atrial Fibrillation During the Period 2013-2020: A Real-Life Study in Spain

Autor: Delgado, O, Sicras-Mainar, A, Pérez Román, I, Salazar, J, del Campo Alonso, MI, Echeto, A, Vilanova, D, Comin-Colet, J

Publikováno v: In Value in Health December 2022 25(12) Supplement:S478-S478

RWD81 Analysis of Clinical Outcomes, Health Resource Use and Costs of Patients With Non-Valvular Atrial Fibrillation Treated With Apixaban vs Acenocoumarol in Routine Clinical Practice in Spain

Autor: Comin-Colet, J, Sicras-Mainar, A, Pérez Román, I, Salazar, J, del Campo Alonso, MI, Echeto, A, Vilanova, D, Delgado, O

Publikováno v: In Value in Health December 2022 25(12) Supplement:S464-S464

Consequences of the Poor Anticoagulation Control of Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonists.

Autor: Sicras Mainar A; Atrys Health, 28021 Madrid, Spain., Salazar-Mendiguchía J; Bristol Myers Squibb, 28050 Madrid, Spain., Del Campo Alonso MI; Bristol Myers Squibb, 28050 Madrid, Spain., Echeto A; Bristol Myers Squibb, 28050 Madrid, Spain., Vilanova Larena D; Bristol Myers Squibb, 28050 Madrid, Spain., Comín Colet J; Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; IDIBELL-Instituto de Investigación Biomédica de Bellvitge, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; CIBERCV-Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares, Universitat de Barcelona, Hospitalet del Llobregat, 08007 Barcelona, Spain.

Publikováno v: Journal of clinical medicine [J Clin Med] 2024 Oct 30; Vol. 13 (21). Date of Electronic Publication: 2024 Oct 30.